Cargando…

Coronavirus disease 2019 pneumonia may present as an acute exacerbation of idiopathic pulmonary fibrosis

Detalles Bibliográficos
Autores principales:	Lee, Yong Hoon, Kim, Chang Ho, Lee, Jaehee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399424/ https://www.ncbi.nlm.nih.gov/pubmed/32802476 http://dx.doi.org/10.21037/jtd-20-1658

Ejemplares similares

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
por: Molyneaux, Philip L., et al.
Publicado: (2017)

Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2022)

Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia
por: Joob, Beuy, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

Unconventional use of high-flow nasal cannula in acute exacerbation of idiopathic pulmonary fibrosis with high levels of hypercapnia
por: Fiorentino, Giuseppe, et al.
Publicado: (2020)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2013)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2018)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2020)

Imaging features of 2019 novel coronavirus pneumonia
por: Xu, Xi, et al.
Publicado: (2020)

How many patients with idiopathic pulmonary fibrosis are there in Brazil?
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kishaba, Tomoo
Publicado: (2019)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kim, Dong Soon
Publicado: (2022)

Pulmonary Fibrosis Due to COVID-19 Pneumonia
por: Kayhan, Servet, et al.
Publicado: (2020)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
por: Papiris, Spyros A., et al.
Publicado: (2019)

Monocyte as a prognostic marker in patients with idiopathic pulmonary fibrosis
por: Zhu, Shiping
Publicado: (2021)

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
por: Moon, Sung Woo, et al.
Publicado: (2019)

Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
por: Bando, Tomohiro, et al.
Publicado: (2022)

Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
por: Tanabe, Naoya, et al.
Publicado: (2021)

Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process
por: Tian, Sufang, et al.
Publicado: (2020)

Approach to acute exacerbation of idiopathic pulmonary fibrosis
por: Bhatti, Hammad, et al.
Publicado: (2013)

Acute exacerbations in patients with idiopathic pulmonary fibrosis
por: Kim, Dong Soon
Publicado: (2013)

Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017)

Acute Exacerbations in Patients With Idiopathic Pulmonary Fibrosis
por: Kim, Dong Soon
Publicado: (2018)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis
por: de Brouwer, Bart, et al.
Publicado: (2018)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
por: Moor, C. C., et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic
por: Faverio, P., et al.
Publicado: (2023)

Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
por: Lim, Jeong Uk, et al.
Publicado: (2019)

COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib
por: Caradec, E., et al.
Publicado: (2021)

Acute exacerbation of post-COVID-19 pulmonary fibrosis: air travel as a potential trigger
por: Amaral, Alexandre Franco, et al.
Publicado: (2021)

Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019
por: Hara, Yu, et al.
Publicado: (2022)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Spontaneous Pneumomediastinum in a Patient with Coronavirus Disease 2019 Pneumonia and the Possible Underlying Mechanism
por: Lei, Pinggui, et al.
Publicado: (2020)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis
por: Oda, Keishi, et al.
Publicado: (2014)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Weng, Dong, et al.
Publicado: (2019)

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
por: Kakugawa, Tomoyuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g4rvi6pv2dp89fjer2hvdtr541